Susquehanna Fundamental Investments, LLC Apellis Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $1.08 Million - $1.73 Million	-35,264 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $9,325 - $20,742	-297 Reduced 0.84%	35,264 $1.16 Million
Q2 2021 Aug 11, 2021	SELL	$40.9 - $64.9 $151,330 - $240,130	-3,700 Reduced 9.42%	35,561 $2.25 Million
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $266,995 - $375,560	6,544 Added 20.0%	39,261 $1.69 Million
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $1.01 Million - $1.87 Million	32,717 New	32,717 $1.87 Million

301

114M

5.21M

691K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.17B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.